Editorial

Blood pressure management in the wake of SPRINT

Edward J. Filippone, MD, FACP and Andrew J. Foy, MD
Cleveland Clinic Journal of Medicine March 2016, 83 (3) 196-198; DOI: https://doi.org/10.3949/ccjm.83a.16015

REFERENCES

  1. ↵
    1. Lim SS,
    2. Vos T,
    3. Flaxman AD,
    4. et al
    . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2224–2260.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Prospective Studies Collaboration
    . Age-specific relevance of usual blood pressure to vascular mortality: a metaanalysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903–1913.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Psaty BM,
    2. Smith NL,
    3. Siscovick DS,
    4. et al
    . Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277:739–745.
    OpenUrlCrossRefPubMed
  4. ↵
    1. SPRINT Research Group
    2. Wright JT Jr.,
    3. Williamson JD,
    4. Whelton PK,
    5. et al
    . A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103–2116.
    OpenUrlCrossRefPubMed
  5. ↵
    1. ACCORD Study Group
    2. Cushman WC,
    3. Evans GW,
    4. Byington RP,
    5. et al
    . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575–1585.
    OpenUrlCrossRefPubMed
  6. ↵
    1. SPS3 Study Group
    2. Benavente OR,
    3. Coffey CS,
    4. Conwit R,
    5. et al
    . Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013; 382:507–515.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Filippone EJ,
    2. Foy A,
    3. Newman E
    . Goal-directed antihypertensive therapy: lower may not always be better. Cleve Clin J Med 2011; 78:123–133.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Lv J,
    2. Neal B,
    3. Ehteshami P,
    4. et al
    . Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Med 2012; 9:e1001293.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Thomas G,
    2. Nally JV,
    3. Pohl MA
    . Interpreting SPRINT: how low should you go? Cleve Clin J Med 2016; 83:187–195.
    OpenUrlAbstract/FREE Full Text

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects